These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9311797)

  • 1. Identification of an immunodominant neutralizing and protective epitope from measles virus fusion protein by using human sera from acute infection.
    Atabani SF; Obeid OE; Chargelegue D; Aaby P; Whittle H; Steward MW
    J Virol; 1997 Oct; 71(10):7240-5. PubMed ID: 9311797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against morbillivirus-induced encephalitis by immunization with a rationally designed synthetic peptide vaccine containing B- and T-cell epitopes from the fusion protein of measles virus.
    Obeid OE; Partidos CD; Howard CR; Steward MW
    J Virol; 1995 Mar; 69(3):1420-8. PubMed ID: 7531779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mimotope from a solid-phase peptide library induces a measles virus-neutralizing and protective antibody response.
    Steward MW; Stanley CM; Obeid OE
    J Virol; 1995 Dec; 69(12):7668-73. PubMed ID: 7494275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against measles virus-induced encephalitis by anti-mimotope antibodies: the role of antibody affinity.
    Olszewska W; Obeid OE; Steward MW
    Virology; 2000 Jun; 272(1):98-105. PubMed ID: 10873752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the antigenic profile of measles virus haemagglutinin in mice and humans using overlapping synthetic peptides.
    Obeid OE; Partidos CD; Steward MW
    Virus Res; 1994 Apr; 32(1):69-84. PubMed ID: 7518172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the neutralizing antibody response to the measles virus using synthetic peptides of the haemagglutinin protein.
    Muller CP; Schroeder T; Tu R; Brons NH; Jung G; Schneider F; Wiesmüller KH
    Scand J Immunol; 1993 Nov; 38(5):463-71. PubMed ID: 7694357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against measles virus encephalitis by monoclonal antibodies binding to a cystine loop domain of the H protein mimicked by peptides which are not recognized by maternal antibodies.
    Ziegler D; Fournier P; Berbers GA; Steuer H; Wiesmüller KH; Fleckenstein B; Schneider F; Jung G; King CC; Muller CP
    J Gen Virol; 1996 Oct; 77 ( Pt 10)():2479-89. PubMed ID: 8887481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological analysis of the protective responses to the chimeric synthetic peptide representing T- and B-cell epitopes from the fusion protein of measles virus.
    Obeid OE; Stanley CM; Steward MW
    Virus Res; 1996 Jun; 42(1-2):173-80. PubMed ID: 8806185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine specificity of the antibody response to a synthetic peptide from the fusion protein and protection against measles virus-induced encephalitis in a mouse model.
    Partidos CD; Ripley J; Delmas A; Obeid OE; Denbury A; Steward MW
    J Gen Virol; 1997 Dec; 78 ( Pt 12)():3227-32. PubMed ID: 9400973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralization of measles virus wild-type isolates after immunization with a synthetic peptide vaccine which is not recognized by neutralizing passive antibodies.
    El Kasmi KC; Fillon S; Theisen DM; Hartter H; Brons NH; Muller CP
    J Gen Virol; 2000 Mar; 81(Pt 3):729-35. PubMed ID: 10675410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramolecular immunodominance and intermolecular selection of H2d-restricted peptides define the same immunodominant region of the measles virus fusion protein.
    Muller CP; Bünder R; Mayser H; Ammon S; Weinmann M; Brons NH; Schneider F; Jung G; Wiesmüller KH
    Mol Immunol; 1995 Jan; 32(1):37-47. PubMed ID: 7870057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies.
    Muñoz-Alía MA; Casasnovas JM; Celma ML; Carabaña J; Liton PB; Fernandez-Muñoz R
    Virus Res; 2017 May; 236():30-43. PubMed ID: 28465158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular basis of the antigenic cross-reactivity between measles and cowpea mosaic viruses.
    Olszewska W; Steward MW
    Virology; 2003 May; 310(1):183-9. PubMed ID: 12788642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hierarchic T-cell help to non-linked B-cell epitopes.
    Brons NH; Blaich A; Wiesmüller KH; Schneider F; Jung G; Muller CP
    Scand J Immunol; 1996 Nov; 44(5):478-84. PubMed ID: 8947599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular basis of virus crossreactivity and neutralisation after immunisation with optimised chimeric peptides mimicking a putative helical epitope of the measles virus hemagglutinin protein.
    El Kasmi KC; Theisen D; Brons NH; Muller CP
    Mol Immunol; 1998 Oct; 35(14-15):905-18. PubMed ID: 9881686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hemagglutinin-derived peptide-vaccine ignored by virus-neutralizing passive antibodies, protects against murine measles encephalitis.
    El Kasmi KC; Theisen D; Brons NH; Ammerlaan W; Klingele M; Truong AT; Muller CP
    Vaccine; 1999 May; 17(19):2436-45. PubMed ID: 10392626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of antibody response to synthetic peptides derived from the fusion protein of measles virus.
    Meqdam M; Mostratos A
    New Microbiol; 1999 Jan; 22(1):19-25. PubMed ID: 10190113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Priming of measles virus-specific CTL responses after immunization with a CTL epitope linked to a fusogenic peptide.
    Partidos CD; Vohra P; Steward MW
    Virology; 1996 Jan; 215(1):107-10. PubMed ID: 8553582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing neutralizing-antibody responses against emerging measles viruses (MVs): immune selection of MV by H protein-specific antibodies?
    Santibanez S; Niewiesk S; Heider A; Schneider-Schaulies J; Berbers GAM; Zimmermann A; Halenius A; Wolbert A; Deitemeier I; Tischer A; Hengel H
    J Gen Virol; 2005 Feb; 86(Pt 2):365-374. PubMed ID: 15659756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deconstructing the antigenic profile of a protective epitope from measles virus fusion protein using overlapping peptides.
    Partidos CD; Salani FB; Ripley J; Steward MW
    Vaccine; 1999 Sep; 18(3-4):321-4. PubMed ID: 10506658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.